Satsuma Pharmaceuticals Inc
STSA
Get informed when a big investor buys or sells
+ FollowMarket Cap$36.47M
Close$
$1.57
42.5% upside
Current Fair Value
42.5% upsideUndervalued by 42.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $36.47 Million |
|---|---|
| Enterprise Value | $17.06 Million |
| Dividend Yield | $1.50 (-) |
| Earnings per Share | $-2.16 |
| Beta | 0.1 |
| Outstanding Shares | 33,152,498 |
Return
| Return on Equity | -168.23% |
|---|---|
| Return on Assets | -145.67% |
| Return on Invested Capital | -175.76% |
Valuation & Multiples
| P/E Ratio | -0.51 |
|---|---|
| PEG | 1.39 |
| Price to Sales | - |
| Price to Book Ratio | 1.1 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.26 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Satsuma Pharmaceuticals Inc
CEO: John Kollins